Home › Case briefs › Constitutional Law

Abbott Laboratories v. Gardner

Supreme Court of the United States · Constitutional Law

Constitutional LawAdministrative LawJudicial ReviewRipenessAPADeclaratory Judgment Actpre-enforcement reviewfinal agency action

Facts

Congress amended the Federal Food, Drug, and Cosmetic Act to require prescription drug manufacturers to print the drug's established name prominently and in type at least half as large as any proprietary name on labels and printed material. After notice and consideration of comments, the Commissioner of Food and Drugs promulgated regulations requiring that the established name accompany each appearance of any proprietary drug name on labels, labeling, and advertisements. A group of drug manufacturers and their trade association challenged the regulations, arguing that the Commissioner exceeded statutory authority by imposing this 'every time' requirement. The regulations were effective immediately, and noncompliance exposed manufacturers to misbranding sanctions, while compliance required extensive and costly changes to labels and promotional materials.

Issue

Whether the Federal Food, Drug, and Cosmetic Act precludes pre-enforcement judicial review of these regulations, and whether the manufacturers' challenge was sufficiently ripe to permit declaratory and injunctive relief before enforcement proceedings were brought. Put differently, the question was whether these regulations constituted final agency action fit for immediate judicial review and whether withholding review would impose sufficient hardship.

Rule

Judicial review of final agency action by an aggrieved person is presumed available unless there is clear and convincing evidence that Congress intended to preclude review. In determining ripeness for pre-enforcement review, courts evaluate both the fitness of the issues for judicial decision and the hardship to the parties of withholding court consideration; a purely legal challenge to a definitive, final regulation that immediately affects day-to-day conduct and exposes the challenger to serious sanctions is ripe absent a statutory bar or other unusual circumstance.

🔒

See the holding & full analysis

Create a free KwikCourt account to unlock the rest of this brief — and practice the case.

The court's holding and reasoning
Doctrine tests, pitfalls & exam hypotheticals
10 practice questions + 4 AI-graded essays on this case

Free sample · practice this case

Test yourself

One of 10 multiple-choice questions for this case. Pick an answer to see why.

The National Consumer Product Bureau adopted a notice-and-comment rule requiring every online listing for household cleaners sold in Phoenix, Arizona and nationwide to repeat the product's federally assigned chemical identifier each time a brand name appears. Mesa Verde Homecare, a manufacturer based in Tucson, claims the statute allows the identifier only once per listing. The rule took effect immediately, and noncompliance exposes sellers to civil fines and product holds, while compliance requires reprogramming thousands of listings.

If Mesa Verde files suit immediately seeking declaratory and injunctive relief that the rule exceeds the agency's statutory authority, which is the strongest argument that the case is ripe?

Explanation. The majority's ripeness inquiry asks both whether the issues are fit for judicial decision and whether withholding review would cause hardship. A purely legal challenge to a final, self-operative rule that immediately affects day-to-day business and forces the regulated party either to incur substantial compliance costs or risk serious sanctions is ripe for pre-enforcement review.